Director Shareholding (9700F)
05 May 2011 - 3:32AM
UK Regulatory
TIDMISPH
RNS Number : 9700F
IS Pharma PLC
04 May 2011
04 May 2011
IS Pharma plc
('IS Pharma' or the 'Company')
Director Shareholding
IS Pharma plc (LSE: ISPH), the international speciality
pharmaceutical company, announces that application has been made
for the admission to trading on AIM of 44,386 new ordinary shares
of 10p each in the capital of the Company ("Ordinary Shares")
issued following the exercise today of options granted to John
Gregory, Chairman, under IS Pharma's unapproved share option
scheme. It is expected that these Ordinary Shares will be admitted
to trading on 10 May 2011.
As a result of this option exercise, John Gregory holds an
interest in 93,701 Ordinary Shares representing 0.18% of the
Company's current issued share capital.
Following the exercise of these options IS Pharma has a total of
52,045,066 Ordinary Shares in issue at the date of this notice with
each share carrying the right to one vote. There are no shares held
in treasury. The total number of voting rights in the Company is
therefore 52,045,066.
The above figure may be used by shareholders as the denominator
for the calculations by which they determine if they are required
to notify their interest in, or a change to their interest in, the
Company under the Disclosure and Transparency Rules.
- Ends -
For further information, call:
IS Pharma plc Tel: +44(0) 1244 625 150
John Gregory, Chairman
Tim Wright, Chief Executive Officer
Matthew Hall, Chief Financial Officer
Financial Dynamics Limited Tel: +44(0) 20 7831 3113
Billy Clegg I Edward Westropp
finnCap Limited Tel: +44 (0)20 7600 1658
Matthew Robinson
Ed Frisby
A copy of this announcement will be available on the website of
IS Pharma at www.ispharma.plc.uk.
IS Pharma (International Speciality Pharmaceuticals) is a fast
growing, profitable business which develops, acquires and
commercialises late-stage pharmaceuticals and medical devices,
focusing in critical care, oncology and neurology. Based in the UK,
IS Pharma commercialises its portfolio in the UK directly and
internationally through a strong network of distributors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFVDELISIIL
IS Pharma (LSE:ISPH)
Historical Stock Chart
From May 2024 to Jun 2024
IS Pharma (LSE:ISPH)
Historical Stock Chart
From Jun 2023 to Jun 2024